MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
AZN — AstraZeneca PLC
NYSEAstraZeneca PLC
$156.90
-0.80(-0.51%)
- O
- 158.46
- H
- 158.80
- L
- 156.41
- V
- 2.64M
⏱️ End-of-day dataAs of Oct 2, 2026
AZN — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $756.00M | $571.10M | $814.30M | $705.80M | $523.00M | $548.80M |
| Other Short Term Investments | $11.50M | $30.00M | $39.00M | $50.00M | $16.50M | $16.60M |
| Accounts Receivable | $1.41B | $1.52B | $1.43B | $1.42B | $1.32B | $1.30B |
| Inventory | $657.00M | $655.70M | $659.30M | $646.70M | $588.40M | $528.80M |
| Hedging Assets | $28.00M | $90.00M | $12.00M | $95.00M | $45.00M | $54.00M |
| Other Current Assets | $17.50M | N/A | N/A | $10.00M | N/A | N/A |
| Total Current Assets | $2.96B | $2.87B | $2.99B | $2.89B | $2.61B | $2.58B |
| Properties | $1.49B | $1.47B | $1.38B | $1.32B | $1.23B | $1.16B |
| Goodwill | $7.93B | $8.03B | $8.06B | $8.04B | $7.98B | $7.92B |
| Financial Assets | $38.20M | $49.80M | $50.20M | $50.90M | $21.00M | $18.20M |
| Intangible Assets | $3.69B | $3.78B | $3.82B | $3.79B | $3.75B | $3.72B |
| Total Non Current Assets | $8.44B | $8.54B | $8.45B | $8.35B | $8.01B | $7.82B |
| Total Assets | $11.40B | $11.41B | $11.45B | $11.24B | $10.63B | $10.40B |
| Accounts Payable | $2.25B | $2.53B | $2.50B | $2.40B | $2.25B | $2.25B |
| Short Term Debt | $795.90M | $348.60M | $655.30M | $685.30M | $340.60M | $249.50M |
| Tax Payable | $129.90M | $108.40M | $126.80M | $142.90M | $165.60M | $140.60M |
| Total Current Liabilities | $3.26B | $3.06B | $3.41B | $3.35B | $2.91B | $2.79B |
| Long Term Provisions | $90.40M | $91.80M | $92.90M | $97.20M | $92.20M | $92.10M |
| Long Term Debt | $2.60B | $2.61B | $2.61B | $2.60B | $2.79B | $2.76B |
| Provision For Risks And Charges | $276.60M | $307.90M | $254.80M | $208.50M | $230.20M | $200.80M |
| Deferred Liabilities | $347.10M | $350.00M | $360.40M | $361.50M | $355.30M | $330.50M |
| Derivative Product Liabilities | $8.00M | 0.00 | 0.00 | 0.00 | $49.00M | $11.50M |
| Total Non Current Liabilities | $3.41B | $3.47B | $3.44B | $3.41B | $3.60B | $3.53B |
| Total Liabilities | $6.66B | $6.54B | $6.85B | $6.76B | $6.51B | $6.32B |
| Common Stock | $38.80M | $38.80M | $38.80M | $38.80M | $38.80M | $38.80M |
| Retained Earnings | $967.20M | $1.10B | $821.30M | $702.30M | $336.40M | $316.00M |
| Total Shareholders Equity | $4.74B | $4.87B | $4.60B | $4.48B | $4.11B | $4.09B |
| Additional Paid In Capital | $3.53B | $3.53B | $3.52B | $3.52B | $3.52B | $3.52B |
| Minority Interest | $51.00M | $52.00M | $83.00M | $91.00M | $92.00M | $85.00M |